中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
23期
3177-3178
,共2页
前列腺炎%左氧氟沙星%坦索罗辛%曲唑酮
前列腺炎%左氧氟沙星%坦索囉辛%麯唑酮
전렬선염%좌양불사성%탄색라신%곡서동
Prostatitis%Levofloxacin%Tamsulosin%Trazodone
目的 探讨左氧氟沙星联合坦索罗辛及曲唑酮治疗慢性非细菌性(Ⅲ型)前列腺炎的疗效. 方法 对118例慢性非细菌性前列腺炎患者采用左氧氟沙星0.2 2次/d+坦索罗辛0.2μg每晚一次+曲唑酮50μg3次/d,口服治疗,疗程4～12周.应用美国国立卫生研究院(NIH)慢性前列腺炎症状评分(NIH-CPSI)标准对治疗前后总评分及所包括的患者疼痛评分、排尿症状评分、生活质量评分并进行统计学分析. 结果 多数患者症状有明显改善,全部患者治疗前后NIH-CPSI总评分分别为(26.81±3.69)分、(13.41±5.31)分比较,差异有统计学意义(P＜0.01);疼痛不适前后评分分别为(12.81±2.52)分、(8.91±3.51)分比较,差异有统计学意义(P＜0.01);排尿症状前后评分分别为(5.76±1.89)分、(2.79±1.38)分(P＜0.01);生活质量前后评分分别为(9.12±3.21)分、(4.28±2.46)分(P＜0.01). 结论 左氧氟沙星联合坦索罗辛及曲唑酮治疗慢性非细菌性(Ⅲ型)前列腺炎效果明显.
目的 探討左氧氟沙星聯閤坦索囉辛及麯唑酮治療慢性非細菌性(Ⅲ型)前列腺炎的療效. 方法 對118例慢性非細菌性前列腺炎患者採用左氧氟沙星0.2 2次/d+坦索囉辛0.2μg每晚一次+麯唑酮50μg3次/d,口服治療,療程4～12週.應用美國國立衛生研究院(NIH)慢性前列腺炎癥狀評分(NIH-CPSI)標準對治療前後總評分及所包括的患者疼痛評分、排尿癥狀評分、生活質量評分併進行統計學分析. 結果 多數患者癥狀有明顯改善,全部患者治療前後NIH-CPSI總評分分彆為(26.81±3.69)分、(13.41±5.31)分比較,差異有統計學意義(P＜0.01);疼痛不適前後評分分彆為(12.81±2.52)分、(8.91±3.51)分比較,差異有統計學意義(P＜0.01);排尿癥狀前後評分分彆為(5.76±1.89)分、(2.79±1.38)分(P＜0.01);生活質量前後評分分彆為(9.12±3.21)分、(4.28±2.46)分(P＜0.01). 結論 左氧氟沙星聯閤坦索囉辛及麯唑酮治療慢性非細菌性(Ⅲ型)前列腺炎效果明顯.
목적 탐토좌양불사성연합탄색라신급곡서동치료만성비세균성(Ⅲ형)전렬선염적료효. 방법 대118례만성비세균성전렬선염환자채용좌양불사성0.2 2차/d+탄색라신0.2μg매만일차+곡서동50μg3차/d,구복치료,료정4～12주.응용미국국립위생연구원(NIH)만성전렬선염증상평분(NIH-CPSI)표준대치료전후총평분급소포괄적환자동통평분、배뇨증상평분、생활질량평분병진행통계학분석. 결과 다수환자증상유명현개선,전부환자치료전후NIH-CPSI총평분분별위(26.81±3.69)분、(13.41±5.31)분비교,차이유통계학의의(P＜0.01);동통불괄전후평분분별위(12.81±2.52)분、(8.91±3.51)분비교,차이유통계학의의(P＜0.01);배뇨증상전후평분분별위(5.76±1.89)분、(2.79±1.38)분(P＜0.01);생활질량전후평분분별위(9.12±3.21)분、(4.28±2.46)분(P＜0.01). 결론 좌양불사성연합탄색라신급곡서동치료만성비세균성(Ⅲ형)전렬선염효과명현.
Objective To elxplore the effect of combined with tamsulosin and trazodone medication in treatment of chronic bacterial prostatitis(CAP,type Ⅲ). Methods 118 cases of CAP were treated with oral levofioxacin + tamsulosin + trazodone for 4 ～ 12 weeks.Statistical analysis was conducted for total scores(including pain score,urinary symptom score and life quality score)according to NIH-CPSI. Results The symptoms were improved in most cases.Before and after treatment,the total scores were of all cases(26.81 ± 3.69)VS(13.41 ± 5.31),the pain score was(12.81 ±2.52)VS(8.91 ±3.51),the urinary symptom score was(5.76 ± 1.89)VS(2.79 ± 1.38),and the life quality score was(9.12 ±3.21)VS(4.28 ±2.46).There was statistically significant difference between them (all P＜0.01). Conclusion Levofloxacin combined with tamsulosin and trazodone medication in treatment of CAP could produce obvious effects.
